Organisation
Department of Pharmaceutics
Department
Current researchers
1 - 10 of 120 results
- Chris Vervaet (Responsible)
- Justine Aelvoet (Member)
- Ilke Aernout (Member)
- Amin Ahmad (Member)
- Mohsin Ali (Member)
- Ruben Almey (Member)
- Dominika Berdecka (Member)
- Danique Berrevoet (Member)
- Louis Bouckaert (Member)
- Kevin Braeckmans (Member)
Projects
1 - 10 of 375
- A platform for the fast development of thermostable lyophilized mRNA lipid nanoparticle (LNP) vaccinesFrom7 Feb 2024 → TodayFunding: Foreign private sponsor - undefined
- Getting picobodies out of their comfort zone - Investigating the in vitro affinity maturation, folding and structure of isolated picobodiesFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Unraveling the role of the immune system in the development of exuberant granulation tissue in horse woundsFrom1 Jan 2024 → TodayFunding: BOF - doctoral mandates
- Design and synthesis of inhibitors of the MEP pathwayFrom1 Jan 2024 → TodayFunding: BOF - doctoral mandates
- DEXTRACs: An innovative concept for targeted degradation of extracellular proteinsFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Uncaging the potential of photopharmacology for the treatment of epilepsyFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- LNP-DECODE: Deciphering the adjuvants activity of lipid nanoparticle-based mRNA vaccines in primary dendritic cellsFrom1 Jan 2024 → TodayFunding: BOF - projects
- Restoring fertility by the 3R-approach : rejuvenating, replacing or reconstructing the oocyteFrom1 Jan 2024 → TodayFunding: BOF - projects
- Evaluation of formulation parameters o n the mRNA integrity within mRNA lipid nanoparticlesFrom20 Dec 2023 → TodayFunding: IOF - technology validation in lab
- Towards clinical testing of novel stabilized less toxic asparaginases for the treatment of acute lymphoblastic leukemiaFrom20 Dec 2023 → TodayFunding: IOF - technology validation in lab
Publications
41 - 50 of 1925
- Azithromycin in uncontrolled asthma(2017)
Authors: Guy Brusselle, Ian Pavord
Pages: 629 - 630 - Reduced frizzled receptor 4 expression prevents WNT/β-catenin-driven alveolar lung repair in chronic obstructive pulmonary disease(2017)
Authors: Wioletta Skronska-Wasek, Kathrin Mutze, Hoeke A Baarsma, Ken Bracke, Hani N Alsafadi, Mareike Lehmann, Rita Costa, Mariano Stornaiuolo, Ettore Novellino, Guy Brusselle, et al.
Pages: 172 - 185 - Safety of reslizumab in uncontrolled asthma with eosinophilia : a pooled analysis from 6 trials(2020)
Authors: J. Christian Virchow, Rohit Katial, Guy Brusselle, Yael Shalit, Margaret Garin, Mirna McDonald, Mario Castro
Pages: 540 - 548.e1 - Safety and effectiveness of as-needed formoterol in asthma patients taking inhaled corticosteroid (ICS)-formoterol or ICS-salmeterol maintenance therapy(2023)
Authors: Helen Kathryn Reddel, Guy Brusselle, Rosa Lamarca, Per Gustafson, Gary P Anderson, Carin Jorup
Pages: 2104 - 2114.e3 - A practice-based analysis of combinations of diseases in patients aged 65 or older in primary care
Authors: Pauline Boeckxstaens, Wim Peersman, Gwendolyn Goubin, Souhila Ghali, Guy Brusselle
- Development and validation of an electronic daily control score for asthma (e-DASTHMA) : a real-world direct patient data study
Authors: Bernardo Sousa-Pinto, Cristina Jacome, Ana Margarida Pereira, Frederico S. Regateiro, Rute Almeida, Wienczyslawa Czarlewski, Marek Kulus, Mohamed H. Shamji, Louis-Philippe Boulet, Matteo Bonini, et al.
Pages: E227 - E238 - Production of bioflavours
Authors: Tom Desmet, An Cerdobbel, Erick Vandamme, Ashok Pandey, Christian Laroche, Carlos Ricardo Soccol, Claude-Gilles Dusap
Pages: 462 - 482 - Sesquiterpenes from selected Laserpitium L. species as antimicrobial agentsVolume: 108
Authors: Visnja Popovic, Dejan Stojkovic, Milos Nikolic, Nadia Bougarne, Arne Heyerick, Marina Sokovic, Johan Van der Eycken, Radmila Rapkova, Michal Jurasek, Pavel Drasar
Pages: s114 - s115 - Twelve-month consumption of a polyphenol extract from olive (Olea europaea) in a double blind, randomized trial increases serum total osteocalcin levels and improves serum lipid profiles in postmenopausal women with osteopenia
Authors: R Filip, Sam Possemiers, Arne Heyerick, I Pinheiro, G Raszewski, MJ Davicco, V Coxam
Pages: 77 - 86 - Gap junctional intercellular communication as a target for liver toxicity and carcinogenicity
Authors: Mathieu Vinken, Tatyana Doktorova, Luc Leybaert, Tamara Vanhaecke, Vera Rogiers
Pages: 201 - 222